Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 785. The contact email is not on this page.
- NURAVAX, INC.
NIH R44: Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AURAGENT BIOSCIENCE, LLC
NIH R44: Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INDELIBLE LEARNING, INC.
NIH R44: Interactive Hand Hygiene Trainer for School-Age Children
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Remedy Plan, Inc.
Form D history: Biotechnology
startup · MD · amount not stated · 2023-08-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-08-10.
- NORTH SHORE THERAPEUTICS, INC.
NIH R41: NST-SPARK: Developing an Augmented Reality (AR) Digital Health Intervention for Negative Symptoms in Schizophrenia
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RALLIDAE THERAPEUTICS, INC
NIH R43: Discovery of a Novel V1aR Partial Agonist
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CALLA HEALTH FOUNDATION
NIH R43: Development and validation of patient-ready Callascope for cervical imaging
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRAMPOLINE PHARMA, INC.
NIH R43: Development of a Universal Next Generation T Cell Receptor Cancer Therapy: Preclinical Proof-of-Concept and Optimization
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENYX THERAPEUTICS, LLC
NIH R41: Gene Therapy-mediated Angiogenesis to Enhance Survival of Transplanted Fat
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VANISH THERAPEUTICS INC.
NIH R41: Opioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VIA THERAPEUTICS, LLC
NIH R41: Dry powders of whole blood prepared by thin-film freeze-drying
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Monument Biosciences
Monument Biosciences is dedicated to bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). The company focuses on advancing new AD targets through diverse therapeutic modalities and potential combination therapy, lev
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ECHOGENESIS THERAPEUTICS INC
NIH R41: Cell type-specific gene therapy approach for TOMT-linked congenital hearing loss
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Thermedical, Inc.
Form D history: Other Health Care
startup · MA · amount not stated · 2021-08-18
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-08-18.
- PEDIADOSE LLC
NIH R43: Novel Mobile Application to Reduce Health Disparities by Improving Dosing Accuracy of Children's Medication
startup · TN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANOVA BIOMEDICAL, INC.
NIH R43: Biodegradable and Elastic Vascular Grafts for Hemodialysis
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEONEURON, LLC
NIH R41: IND-enabling studies for cell therapy in Parkinson's disease
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GMJ TECHNOLOGIES, INC.
NIH R44: High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Neurodon Corp
Form D history: Pharmaceuticals
startup · IN · amount not stated · 2019-11-07
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2019-11-07.
- MOUNTAINPASS TECHNOLOGY, LLC
NIH R42: MyTrials: An Integrated Tool to Support Remote Biomarker Capture within Decentralized Clinical Trials for Substance Use Disorders
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOSETTIA, INC.
NIH R43: Targeting endogenous retrovirus Gag genes for biomarker development in type 1 diabetes
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TEX IMMUNETICS INC
NIH R41: Immune Checkpoint Blockade Therapy to Treat Chronic Bone and Joint Infections
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RYBODYN, INC.
NIH R43: A novel spatial biology platform for protein profiling which is cost effective and scalable
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EVOQ THERAPEUTICS, INC.
NIH R44: NanoDiscs for Immune Modulation in Celiac Disease
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AFFINERGY, LLC
NIH R44: A novel peptide assay for hepcidin clinical monitoring
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AVERY BIO CORPORATION
NIH R43: Long DNA Assembly on Electronic Nanochannel Chip Devices
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SYMPHONY BIOSCIENCES, INC.
NIH R44: Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAPESYM, INC.
NIH R44: High-Resolution Direct-Conversion X-ray Detectors for Low-Dose Imaging
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOPEPTIDES, INC.
NIH R44: A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIO TILLION, LLC
NIH R44: End to End, Cold Chain Validation Using Sample Attached History Log
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Creative BioTherapeutics LLC
Form D history: Biotechnology
startup · IL · amount not stated · 2025-07-29
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-07-29.
- ENTANGL3D, LLC
NIH R43: Stiff and Tough Bioadhesive Patch to Limit Recurrent Disc Prolapse
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FRD ACCEL, LLC
NIH R41: Transforming Trauma Care: Innovative Solutions for Enhancing Behavioral Health Outcomes
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ABLELINK SMART LIVING TECHNOLOGIES LLC
NIH R44: Development and Evaluation of Technology and Safety Supports for Individuals with Intellectual and Developmental Disabilities to Independently Use Driverless and Driver Supported Ridehailing Services
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Predictably Human, Inc.
Form D history: Other Health Care
startup · CT · amount not stated · 2025-01-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-01-10.
- NanoPharmaceuticals LLC
Form D history: Pharmaceuticals
startup · NY · amount not stated · 2025-02-04
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-02-04.
- OGB4 INC
NIH R44: Rho GTPase inhibitor for refrigerated platelet storage
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ALTEC, INC.
NIH R44: Adaptive & Individualized AAC
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Partillion Bioscience Corp
Form D history: Biotechnology
startup · CA · amount not stated · 2022-12-30
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-12-30.
- PARMEDICS, INC.
NIH R44: Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.